Drug-related problems and challenges encountered by pharmacists in nirmatrelvir/ritonavir counselling during the covid-19 pandemic: a multi-center study.

ABSTRACT: Pharmacists' counselling roles expanded significantly during the COVID-19 pandemic, yet drug-related problems (DRPs) and challenges during nirmatrelvir/ritonavir counselling remain underreported. The study aimed to characterise the DRPs and challenges encountered during nirmatrelvir/ritonavir counselling by pharmacists in the central region of Malaysia. A cross-sectional study was conducted in government hospitals and primary care clinics involving patients who received nirmatrelvir/ritonavir counselling from July to September 2022. The DRPs were adapted from a classification system for intermediate and long-term care settings. Descriptive analysis was conducted using SPSS version 20. The study included 3,626 patients, aged 18 to 99 years (54.56 ± 17.66). Overall, 2,371 (65.39%) patients h

SUBMITTER: Balan S 

PROVIDER: S-EPMC12484732 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature